These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8832221)

  • 1. Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis.
    Campanile F; Giampietri A; Grohmann U; Belladonna ML; Fioretti MC; Puccetti P
    Eur J Pharmacol; 1996 Jun; 307(2):191-9. PubMed ID: 8832221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10.
    Grohmann U; Van Snick J; Campanile F; Silla S; Giampietri A; Vacca C; Renauld JC; Fioretti MC; Puccetti P
    J Immunol; 2000 Apr; 164(8):4197-203. PubMed ID: 10754315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock.
    Lechner AJ; Rouben LR; Potthoff LH; Tredway TL; Matuschak GM
    Circ Shock; 1993 Apr; 39(4):306-15. PubMed ID: 8485822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo therapeutics of β-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice.
    Shih MF; Chen LY; Tsai PJ; Cherng JY
    Int J Immunopathol Pharmacol; 2012; 25(1):39-48. PubMed ID: 22507316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa.
    Gosselin D; DeSanctis J; Boulé M; Skamene E; Matouk C; Radzioch D
    Infect Immun; 1995 Sep; 63(9):3272-8. PubMed ID: 7642255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin, tumor necrosis factor alpha and neutrophils: causative relationship in indomethacin-induced stomach injuries.
    Ding SZ; Lam SK; Yuen ST; Wong BC; Hui WM; Ho J; Guo X; Cho CH
    Eur J Pharmacol; 1998 May; 348(2-3):257-63. PubMed ID: 9652341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase inhibitors enhance tumour necrosis factor production and mortality in murine endotoxic shock.
    Pettipher ER; Wimberly DJ
    Cytokine; 1994 Sep; 6(5):500-3. PubMed ID: 7827287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effect of IL-4 on resistance to systemic gram-negative infection and production of TNF-alpha.
    Giampietri A; Grohmann U; Vacca C; Fioretti MC; Puccetti P; Campanile F
    Cytokine; 2000 Apr; 12(4):417-21. PubMed ID: 10805227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.
    Silva AT; Bayston KF; Cohen J
    J Infect Dis; 1990 Aug; 162(2):421-7. PubMed ID: 2373872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial cardiopulmonary effects of pentoxifylline in experimental sepsis are lost once septic shock is established.
    Ridings PC; Windsor AC; Sugerman HJ; Kennedy E; Sholley MM; Blocher CR; Fisher BJ; Fowler AA
    Arch Surg; 1994 Nov; 129(11):1144-52. PubMed ID: 7979946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of endotoxin shock by the dried preparation of low virulent Streptococcus pyogenes OK-432.
    Nose M; Uzawa A; Nomura M; Ikarashi Y; Nakata Y; Akashi M; Suzuki G
    Cell Immunol; 1998 Sep; 188(2):97-104. PubMed ID: 9756639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nitric oxide on beta-glucan/indomethacin-induced septic shock.
    Nameda S; Saito M; Miura NN; Adachi Y; Ohno N
    Biol Pharm Bull; 2005 Jul; 28(7):1254-8. PubMed ID: 15997109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated hematopoietic recovery and protective effect of the cyclooxygenase inhibitor indomethacin in bacterial infection of neutropenic mice.
    Campanile F; Giampietri A; Grohmann U; Binaglia L; Fioretti MC; Puccetti P
    Cell Immunol; 1993 Apr; 147(2):341-52. PubMed ID: 8453676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of TNF-alpha improves indomethacin-induced enteropathy in rats by modulating iNOS expression.
    Saud B; Nandi J; Ong G; Finocchiaro S; Levine RA
    Dig Dis Sci; 2005 Sep; 50(9):1677-83. PubMed ID: 16133968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide.
    Enkhbaatar P; Okajima K; Uchiba M; Isobe H; Okabe H
    Thromb Haemost; 2001 Dec; 86(6):1573-7. PubMed ID: 11776329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-induced, nitric oxide-dependent, intracellular antirickettsial activity of mouse endothelial cells.
    Walker DH; Popov VL; Crocquet-Valdes PA; Welsh CJ; Feng HM
    Lab Invest; 1997 Jan; 76(1):129-38. PubMed ID: 9010456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice.
    Chorinchath BB; Kong LY; Mao L; McCallum RE
    J Immunol; 1996 Feb; 156(4):1525-30. PubMed ID: 8568256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
    Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosine-phosphate-guanine (CpG) motifs are sensitizing agents for lipopolysaccharide in toxic shock model.
    Cornélie S; Wiel E; Lund N; Lebuffe G; Vendeville C; Riveau G; Vallet B; Ban E
    Intensive Care Med; 2002 Sep; 28(9):1340-7. PubMed ID: 12209287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.